Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Implantable Cardioverter Defibrillator Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Implantable Cardioverter Defibrillator Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
      • 1.3.3 Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
      • 1.3.4 Cardiac Resynchronization Therapy Defibrillator (CRT-D)
    • 1.4 Market Segment by Application
      • 1.4.1 Global Implantable Cardioverter Defibrillator Market Share by Application (2019-2025)
      • 1.4.2 ASCs
      • 1.4.3 Hospital
      • 1.4.4 Clinic
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Implantable Cardioverter Defibrillator Production Value 2014-2025
      • 2.1.2 Global Implantable Cardioverter Defibrillator Production 2014-2025
      • 2.1.3 Global Implantable Cardioverter Defibrillator Capacity 2014-2025
      • 2.1.4 Global Implantable Cardioverter Defibrillator Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Implantable Cardioverter Defibrillator Market Size CAGR of Key Regions
      • 2.2.2 Global Implantable Cardioverter Defibrillator Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Implantable Cardioverter Defibrillator Capacity by Manufacturers
      • 3.1.2 Global Implantable Cardioverter Defibrillator Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Implantable Cardioverter Defibrillator Revenue by Manufacturers (2014-2019)
      • 3.2.2 Implantable Cardioverter Defibrillator Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Implantable Cardioverter Defibrillator Market Concentration Ratio (CR5 and HHI)
    • 3.3 Implantable Cardioverter Defibrillator Price by Manufacturers
    • 3.4 Key Manufacturers Implantable Cardioverter Defibrillator Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Implantable Cardioverter Defibrillator Market
    • 3.6 Key Manufacturers Implantable Cardioverter Defibrillator Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS) Production and Production Value (2014-2019)
      • 4.1.2 Transvenous Implantable Cardioverter-Defibrillator (T-ICDs) Production and Production Value (2014-2019)
      • 4.1.3 Cardiac Resynchronization Therapy Defibrillator (CRT-D) Production and Production Value (2014-2019)
    • 4.2 Global Implantable Cardioverter Defibrillator Production Market Share by Type
    • 4.3 Global Implantable Cardioverter Defibrillator Production Value Market Share by Type
    • 4.4 Implantable Cardioverter Defibrillator Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Implantable Cardioverter Defibrillator Consumption by Application

    6 Production by Regions

    • 6.1 Global Implantable Cardioverter Defibrillator Production (History Data) by Regions 2014-2019
    • 6.2 Global Implantable Cardioverter Defibrillator Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Implantable Cardioverter Defibrillator Production Growth Rate 2014-2019
      • 6.3.2 United States Implantable Cardioverter Defibrillator Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Implantable Cardioverter Defibrillator Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Implantable Cardioverter Defibrillator Production Growth Rate 2014-2019
      • 6.4.2 European Union Implantable Cardioverter Defibrillator Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Implantable Cardioverter Defibrillator Import & Export
    • 6.5 China
      • 6.5.1 China Implantable Cardioverter Defibrillator Production Growth Rate 2014-2019
      • 6.5.2 China Implantable Cardioverter Defibrillator Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Implantable Cardioverter Defibrillator Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Implantable Cardioverter Defibrillator Consumption by Regions

    • 7.1 Global Implantable Cardioverter Defibrillator Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Implantable Cardioverter Defibrillator Consumption by Type
      • 7.2.2 United States Implantable Cardioverter Defibrillator Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Implantable Cardioverter Defibrillator Consumption by Type
      • 7.3.2 European Union Implantable Cardioverter Defibrillator Consumption by Application
    • 7.4 China
      • 7.4.1 China Implantable Cardioverter Defibrillator Consumption by Type
      • 7.4.2 China Implantable Cardioverter Defibrillator Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Implantable Cardioverter Defibrillator Consumption by Type
      • 7.5.2 Rest of World Implantable Cardioverter Defibrillator Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 ZOLL Medical Corporation (US)
      • 8.1.1 ZOLL Medical Corporation (US) Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Implantable Cardioverter Defibrillator
      • 8.1.4 Implantable Cardioverter Defibrillator Product Introduction
      • 8.1.5 ZOLL Medical Corporation (US) Recent Development
    • 8.2 Boston Scientific Corporation (US)
      • 8.2.1 Boston Scientific Corporation (US) Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Implantable Cardioverter Defibrillator
      • 8.2.4 Implantable Cardioverter Defibrillator Product Introduction
      • 8.2.5 Boston Scientific Corporation (US) Recent Development
    • 8.3 BIOTRONIK SE & Co. KG (Germany)
      • 8.3.1 BIOTRONIK SE & Co. KG (Germany) Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Implantable Cardioverter Defibrillator
      • 8.3.4 Implantable Cardioverter Defibrillator Product Introduction
      • 8.3.5 BIOTRONIK SE & Co. KG (Germany) Recent Development
    • 8.4 Medtronic PLC (Ireland)
      • 8.4.1 Medtronic PLC (Ireland) Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Implantable Cardioverter Defibrillator
      • 8.4.4 Implantable Cardioverter Defibrillator Product Introduction
      • 8.4.5 Medtronic PLC (Ireland) Recent Development
    • 8.5 St. Jude Medical (US)
      • 8.5.1 St. Jude Medical (US) Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Implantable Cardioverter Defibrillator
      • 8.5.4 Implantable Cardioverter Defibrillator Product Introduction
      • 8.5.5 St. Jude Medical (US) Recent Development
    • 8.6 Koninklijke Philips N.V. (Netherlands)
      • 8.6.1 Koninklijke Philips N.V. (Netherlands) Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Implantable Cardioverter Defibrillator
      • 8.6.4 Implantable Cardioverter Defibrillator Product Introduction
      • 8.6.5 Koninklijke Philips N.V. (Netherlands) Recent Development
    • 8.7 Medtronic Plc
      • 8.7.1 Medtronic Plc Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Implantable Cardioverter Defibrillator
      • 8.7.4 Implantable Cardioverter Defibrillator Product Introduction
      • 8.7.5 Medtronic Plc Recent Development
    • 8.8 PHILIPS HEALTHCARE
      • 8.8.1 PHILIPS HEALTHCARE Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Implantable Cardioverter Defibrillator
      • 8.8.4 Implantable Cardioverter Defibrillator Product Introduction
      • 8.8.5 PHILIPS HEALTHCARE Recent Development
    • 8.9 Sorin Group
      • 8.9.1 Sorin Group Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Implantable Cardioverter Defibrillator
      • 8.9.4 Implantable Cardioverter Defibrillator Product Introduction
      • 8.9.5 Sorin Group Recent Development
    • 8.10 Nihon Kohden Corporation
      • 8.10.1 Nihon Kohden Corporation Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Implantable Cardioverter Defibrillator
      • 8.10.4 Implantable Cardioverter Defibrillator Product Introduction
      • 8.10.5 Nihon Kohden Corporation Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Implantable Cardioverter Defibrillator Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Implantable Cardioverter Defibrillator Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Implantable Cardioverter Defibrillator Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Implantable Cardioverter Defibrillator Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Implantable Cardioverter Defibrillator Production Forecast by Type
      • 9.7.2 Global Implantable Cardioverter Defibrillator Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Implantable Cardioverter Defibrillator Sales Channels
      • 10.2.2 Implantable Cardioverter Defibrillator Distributors
    • 10.3 Implantable Cardioverter Defibrillator Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      An implantable cardioverter defibrillator is a device that monitors a person's heart rate post its implantation in patients with heart failure. The device continuously monitors your heartbeat and sends electrical pulses to repair a normal heart rhythm when necessary. Implantable cardioverter defibrillator (ICD) or automated implantable cardioverter defibrillators can save patients from arrhythmias by regulating the irregular heartbeats. The device is used in treating sudden cardiac arrest caused due to cardiac arrhythmias, particularly ventricular fibrillation and pulseless ventricular tachycardia.
      In 2019, the market size of Implantable Cardioverter Defibrillator is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Implantable Cardioverter Defibrillator.

      This report studies the global market size of Implantable Cardioverter Defibrillator, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Implantable Cardioverter Defibrillator production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      ZOLL Medical Corporation (US)
      Boston Scientific Corporation (US)
      BIOTRONIK SE & Co. KG (Germany)
      Medtronic PLC (Ireland)
      St. Jude Medical (US)
      Koninklijke Philips N.V. (Netherlands)
      Medtronic Plc
      PHILIPS HEALTHCARE
      Sorin Group
      Nihon Kohden Corporation

      Market Segment by Product Type
      Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
      Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
      Cardiac Resynchronization Therapy Defibrillator (CRT-D)

      Market Segment by Application
      ASCs
      Hospital
      Clinic

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Implantable Cardioverter Defibrillator status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Implantable Cardioverter Defibrillator manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Implantable Cardioverter Defibrillator are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now